24.03.2013 Views

o-TOLUIDINE CAS N°: 95-53-4 - UNEP Chemicals

o-TOLUIDINE CAS N°: 95-53-4 - UNEP Chemicals

o-TOLUIDINE CAS N°: 95-53-4 - UNEP Chemicals

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

OECD SIDS o-<strong>TOLUIDINE</strong><br />

5. TOXICITY ID: <strong>95</strong>-<strong>53</strong>-4<br />

DATE: 07.01.2005<br />

CLINICAL SIGNS: no differences to negative controls<br />

BODY WEIGHT: no differences to negative controls; positive control rats<br />

showed significantly reduced body weights.<br />

HISTOPATHOLOGY<br />

NON-NEOPLASTIC LESIONS - LIVER - CELL NECROSIS:<br />

6/60 low dose-, 9/60 high-dose rats<br />

Comparison to controls:<br />

untreated controls: 4/60<br />

peanut-oil : 4/60<br />

Benzidin(low-mid-high dose): 5/60-23/60-33/60<br />

TUMOUR INCIDENCE OVERVIEW<br />

---maligne tumor: injection site<br />

control(peanut oil), m: 6/30; f: 2/30<br />

o-toluidineHCl: low dose: m: 7/60, f: 1/30<br />

high dose: m 14/30, f: 4/30<br />

evaluated by the authors as statistically relvant hints to a dose related<br />

effect<br />

Test condition : TEST ORGANISMS<br />

- Age: 6 weeks<br />

- Number of animals: 30 rats/sex/group including negative controls and<br />

positive control groups<br />

ADMINISTRATION / EXPOSURE<br />

- Type of exposure: subcutan<br />

- Vehicle: peanut oil<br />

- Application volume: 1 ml/kg bw<br />

-dose selection based on determination of LD50-values<br />

- controls:<br />

----negative control: peanut oil treated rats and<br />

--------------------- untreated rats<br />

----positive control: benzidin treated rats(0.93, 8.33, 25 mg/kg bw/day)<br />

CLINICAL OBSERVATIONS AND FREQUENCY<br />

- Body weight: no data on frequency<br />

- Clinical signs: no data on frequency<br />

- Mortality: no data on frequency<br />

HISTOPATHOLOGY<br />

all organs and tissues suspected tumour-bearing<br />

area of injection, liver, lungs, spleen, urinary bladder, brain<br />

Conclusion : Author concluded: o-toluidine causes tumours only under extrem<br />

conditiones<br />

Reliability : (2) valid with restrictions<br />

Study doesn't meet the criteria of today: number of animals to low,<br />

application route and procedure not typical for the human situation, only 2<br />

dosages, no GLP, no individual animal data given<br />

25.05.2004 (151)<br />

Species : mouse<br />

Sex : no data<br />

Strain : other: CC 57<br />

Route of admin. : s.c.<br />

Exposure period : 23 weeks<br />

Frequency of treatm. : once / week<br />

Post exposure period :<br />

Doses : 0. 5 mg<br />

Result :<br />

Control group : yes<br />

Method : other: no data<br />

Year : 1978<br />

GLP : no data<br />

<strong>UNEP</strong> PUBLICATIONS 251

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!